Our finding that TAZ regulates the activity of the NF-κB signaling pathway may provide additional insights into the manner in which the NF-κB signaling pathway could be fine-tuned and precisely controlled during osteoclast-mediated osteoporosis. Here, NFKB1 is linked to osteoporosis.